Jameel Nazir

Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice

Christopher R. Chapple, Jameel Nazir, Zalmaï Hakimi et al. · European Urology · 2017 · 202 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Quinolone-Resistant Haemophilus influenzae in a Long-Term Care Facility: Clinical and Molecular Epidemiology

Jameel Nazir, Carl Urban, N Mariano et al. · Clinical Infectious Diseases · 2004 · 59 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany

Maureen Watt, Charles McCrea, Sukhvinder Johal et al. · Infection · 2016 · 45 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy

Scott MacDiarmid, Jack Barkin, Aino Fianu-Jonasson et al. · The Journal of Urology · 2016 · 44 citations · Full text

Medicine, Pharmacotherapy, Urology +17

The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving <scp>C5</scp> inhibitors in France, Germany and the United Kingdom: Patient‐reported insights on symptoms and quality of life

Jens Panse, Flore Sicre de Fontbrune, Pascale Burmester et al. · European Journal Of Haematology · 2022 · 37 citations · Full text

Medicine, Hematology, Pharmacoeconomics +6